Johnson & Johnson partners with DoSomething.org on college bone marrow drives through Be the Match. JOHNSON & JOHNSON

5 Ways Johnson & Johnson Supports Health and Wellness in the African-American Community

Johnson & Johnson is No. 5 on the DiversityInc Top 50 Companies list


(Originally published on JnJ.com)

Campaigns to increase bone marrow registration. Leadership training for nurses. A push for diversity in clinical trials. These are just a few of the ways that Johnson & Johnson is striving to help transform the health of African-Americans and other minorities.

And the need for that transformation is great.

“The African-American community is disproportionately affected by a number of health concerns, such asdiabetes,prostate cancer, lupus andpreterm births,” explainsWanda Bryant Hope,Chief Diversity & Inclusion Officer, Johnson & Johnson.

“Raising awareness of these conditions and what individuals can do to manage them is criticaland we must do this in a way that is relevant for the community.”

Johnson & Johnson’s commitment to helping communities in need is actually woven into the fabric of its companyCredoa mission statement that highlights its responsibilities to the patients, doctors and customers who use its products; its own employees; and the communities it serves.

ForBlack History Month, we’re spotlighting how the company has honored that Credo mission to help African-American communities throughout the United States.

1. Partnering With the Black AIDS Institute to Help Reduce HIV Infections

Access to healthcare and important information about diseases and treatments varies greatly throughout the United Statesincluding places where a large number of African-Americans call home.

“That’s why our efforts with medical professionals are just as important as our patient-focused efforts,” says Hope.

One example of this is the work Johnson & Johnson has been doing with theBlack AIDS Instituteto help reduce theincreasing rates of HIVinfections among African-Americans.

According to a recent study conducted by the Institute, many community workers responsible for supporting those most at risk for HIV aren’tas well-versedin the latest science, and sometimes even basic knowledge, about the disease. So Johnson & Johnsona partner on the studyis working with the Institute to help develop strategies for providing better education to people on the front lines of HIV care.

For more than a decade, Janssen Therapeutics, part of the Johnson & Johnson family of companies, has alsoawarded grantsto local organizations that are helping to advance access to quality care, including those living in the South and other rural areas of the country.

2. Boosting Bone Marrow Donor Registration Through DoSomething.org

If you have a disease that requires a bone marrow or cord blood transplant for treatment, finding the right genetic match for a donation is crucialand ethnic background plays a big factor in locating that ideal match.

The African-American community is particularly underrepresented in theNational Marrow Donor Programregistryand African-American patients have the lowest chance among all ethnic groups of finding a bone marrow donor. So for people with a life-threatening blood condition, like sickle cell disease orblood cancer, a potential match may be even more out of reach.

To help narrow that match gap, Johnson & Johnson partnered withDoSomething.orgthrough their Give a Spit About Cancer campaign withBe The Matchto educate young people about the need for diverse donors. The result: almost 90,000 people signed up to be part of the campaign, and more than 2,500 ultimately joined the registry by providing a cheek swab to be analyzed in a lab for specific proteins critical for a successful transplant.

Want to register Head toGive a Spitto learn more about the upcoming 2018 campaign.

3. Providing Free Eye Evaluations Together With the National Urban League

For the past seven years,Johnson & Johnson Visionhas offered vision evaluations at theNational Urban League(NUL) annual conference. Each year, hundreds of attendees, who may not have otherwise had the opportunity, can meet with vision experts to get eye screeningsthat include glaucoma testing and a high-tech retina scan.

The goal: educate morepeople about eye health and help diagnose any eye or systemic health issues people may be having without even realizing it, such as complications from diabetes or high blood pressuretwo health conditions that are prevalent in the African-American community.

4. Elevating Nursing Through the Johnson & Johnson Campaign for Nursing

For the past 16 years, Johnson & Johnson has worked to help advance the nursing profession through itsCampaign for Nursingand a variety of other programs that provide grants and scholarships to nurses who want to advance their skills.

As part of this program, several initiatives have focused on programs that help benefit nurses within the African-American community, such as theJohnson & Johnson Campaign for NursingAACN Minority Nurse Faculty Scholarship.

Since 2008, the company has donated more than $1 million to this graduate student scholarship program, which was created to address the nursing faculty shortage and enhance diversity among nurse educators.

Johnson & Johnson has also provided an additional $1 million to theRobert Wood Johnson Foundation Future of Nursing Scholarsprogram to help create a more diverse cadre of Ph.D.-prepared nurses.

5. Promoting More Diversity in Clinical Drug Trials

In 2016, 76% of participants in clinical trials were white. African-Americans, who represent more than 12% of the U.S. population, made up only 5% of study subjects.

This lack of diversity can diminish the effectiveness of certain types of treatmentespecially if that treatment is for a condition that disproportionately impacts the excluded group.

That’s why theJanssen Research & DevelopmentLeadership Chapter of the African-American Leadership Council (AALC) is working to increase the number of minorities who participate in clinical trials through outreach among Johnson & Johnson employees, information booths at national conferences like theNULand speaking engagements sponsored by TheHenrietta Lacks Foundation.

Homer Adams III, a Translational Research Scientist at Janssen Oncology, part of the Johnson & Johnson family of companies, has been spearheading much of this effort. He believes that this work will not only help improve the overall effectiveness of medications, but also the quality of his own research.

“I work onmultiple myeloma, a type of blood cancer that has a higher prevalence among people of African descent,” he says. “Understanding why a drug doesor does notwork for African-Americans is critically important to helping treat many of the people who are affected.”

Learn about career opportunities at Johnson & Johnson

Latest News

Syracuse University campus

News Roundup: TV Diversity, Syracuse Hire, and Segregated Training

Check out our news roundup of diversity and inclusion updates and insights from across the U.S.: Syracuse University Creates Athletics Diversity Position  While most colleges and universities around the county are making COVID-19-related cuts in regard to their athletic departments, Syracuse University has hired Salatha T. Willis as the associate athletic…

Cesar Conde

NBCUniversal Sets Ambitious 50% Diversity Goal for Women, People of Color

Cesar Conde, chairman at NBCUniversal News Group, announced a groundbreaking goal to have a 50% diverse workforce at NBCUniversal, according to Deadline. Conde, the first Latino in this role, outlined his plans in an internal video for employees on Wednesday. The ultimate goal is for NBCUniversal, No. 7 on DiversityInc’s 2020…

Stop TB Partnership and Johnson & Johnson, with support from USAID and The Global Fund, Announce Price Reduction for SIRTURO® (bedaquiline) for Treatment of Drug-Resistant Tuberculosis in Low- and Middle-Income Countries

Originally published on jnj.com. Joint efforts aim to accelerate scale-up of WHO-recommended all-oral treatment regimens – a transition urgently needed to help protect the health of people with drug resistant-tuberculosis who are particularly vulnerable during COVID-19 pandemic In 2020, the initiative aims to reach at least 125,000 patients and could…

Toyota, Alabama A&M and Huntsville Hospital Collaborate to Make COVID-19 Testing Easier

Originally published on pressroom.toyota.com. $100,000 grant provides free service to the community Alabama A & M University (AAMU), Huntsville Hospital and Toyota are developing a mobile health clinic initiative to provide free COVID-19 testing to underserved communities in Madison County. Launching later this year, the mobile medical clinic program has…

Sanofi and Regeneron Provide Update on Kevzara® (sarilumab) Phase 3 U.S. Trial in COVID-19 Patients

Originally published on sanofi.com. Sanofi and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Phase 3 trial of Kevzara® (sarilumab) 400 mg in COVID-19 patients requiring mechanical ventilation did not meet its primary and key secondary endpoints when Kevzara was added to best supportive care compared to best supportive care alone (placebo)….

TD Bank: How a PPP Loan Saved Essential Jobs for Hundreds of Frontline Healthcare Heroes Amid COVID-19

Originally published on newscenter.td.com. Yet, “it’s not about earning a paycheck” for these medical responders A hero is defined as “a person who is admired or idealized for courage, outstanding achievements or noble qualities.” Never has that word resonated more than right now, with millions of frontline responders risking their…

Boeing Dreamlifter Transports 500,000 Protective Face Masks for Utah Students and Teachers

Originally published on boeing.mediaroom.com. Partnered with the state of Utah, Atlas Air, H.M. Cole, Cotopaxi, Flexport and UPS to deliver face masks to school districts with the greatest need Boeing [NYSE: BA] today completed its 12th COVID-19 transport mission, using a Boeing Dreamlifter to bring personal protective equipment (PPE) to the United…